STOCK TITAN

Novanta (NOVT) CEO sells 6,500 shares in Rule 10b5-1 plan trades

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Novanta Inc. director and CEO Matthijs Glastra reported open-market sales of 6,500 shares of common stock on June 2, 2026. The shares were sold in multiple transactions at prices ranging from $164.61 to $171.28, according to the Form 4 data.

The filing shows Glastra now directly owns 42,723 Novanta shares and indirectly holds 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust. The sales were executed under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025, indicating they were pre-arranged rather than discretionary trades.

Positive

  • None.

Negative

  • None.
Insider Glastra Matthijs
Role Chief Executive Officer
Sold 6,500 shs ($1.10M)
Type Security Shares Price Value
Sale Common Stock 38 $164.61 $6K
Sale Common Stock 500 $166.19 $83K
Sale Common Stock 1,420 $167.68 $238K
Sale Common Stock 2,841 $168.76 $479K
Sale Common Stock 1,301 $169.76 $221K
Sale Common Stock 400 $171.28 $69K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 42,723 shares (Direct, null); Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee. This transaction was executed in multiple trades ranging from $165.87 to $166.41. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $167.11 to $168.05. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $168.30 to $169.30. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $169.39 to $170.11. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $170.78 to $171.70. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares sold 6,500 shares Total common shares sold on June 2, 2026
Sale price range $164.61–$171.28 per share Range of reported sale prices on June 2, 2026
Direct holdings after sale 42,723 shares Common stock directly owned following transactions
Indirect holdings via trust 54,382 shares Common stock held through Matthijs Glastra 2021 Irrevocable Trust
Transaction date June 2, 2026 Date of reported open-market sales
Trading plan adoption date September 11, 2025 Adoption date of pre-established Rule 10b5-1 plan
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported above reflects the weighted-average price."
irrevocable trust financial
"Matthijs Glastra 2021 Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"ownership_type": "indirect""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Glastra Matthijs

(Last)(First)(Middle)
C/O NOVANTA INC.
125 MIDDLESEX TURNPIKE

(Street)
BEDFORD MASSACHUSETTS 01730

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026S(1)38D$164.6142,723D
Common Stock06/02/2026S(1)500D$166.19(2)42,223D
Common Stock06/02/2026S(1)1,420D$167.68(3)40,803D
Common Stock06/02/2026S(1)2,841D$168.76(4)37,962D
Common Stock06/02/2026S(1)1,301D$169.76(5)36,661D
Common Stock06/02/2026S(1)400D$171.28(6)36,261D
Common Stock54,382IMatthijs Glastra 2021 Irrevocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.
2. This transaction was executed in multiple trades ranging from $165.87 to $166.41. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. This transaction was executed in multiple trades ranging from $167.11 to $168.05. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. This transaction was executed in multiple trades ranging from $168.30 to $169.30. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. This transaction was executed in multiple trades ranging from $169.39 to $170.11. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
6. This transaction was executed in multiple trades ranging from $170.78 to $171.70. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
Power of Attorney on file
/s/ John Burke, Attorney-in-Fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

How many Novanta (NOVT) shares did CEO Matthijs Glastra sell?

Matthijs Glastra sold a total of 6,500 Novanta common shares in reported transactions. The Form 4 shows several open-market sales on June 2, 2026, each at different prices but together totaling 6,500 shares sold.

At what prices did the Novanta (NOVT) CEO sell his shares?

The reported sales occurred at prices ranging from $164.61 to $171.28 per share. Multiple trades were executed within narrower ranges, with weighted-average prices reported for each transaction as disclosed in the Form 4 footnotes.

How many Novanta (NOVT) shares does CEO Matthijs Glastra still own after the sale?

After these transactions, Matthijs Glastra directly owns 42,723 Novanta shares. The Form 4 also reports an additional 54,382 shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust, giving a larger total associated position.

Were the Novanta (NOVT) CEO’s share sales made under a Rule 10b5-1 plan?

Yes. The filing states the sales were executed under a pre-established Rule 10b5-1 trading plan. The plan was adopted on September 11, 2025 through a trust where the CEO’s spouse serves as trustee, indicating pre-arranged trading.

What is the role of the Matthijs Glastra 2021 Irrevocable Trust in Novanta (NOVT) holdings?

The Form 4 reports 54,382 Novanta shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust. A footnote explains the Rule 10b5-1 trading plan was adopted through this trust, for which the reporting person’s spouse is a trustee.

What does the Novanta (NOVT) Form 4 reveal about the type of transactions?

The Form 4 describes the CEO’s trades as open-market sales of common stock, coded as “S” transactions. Footnotes explain several were executed in multiple trades within specified price ranges, reported using weighted-average prices for each transaction.